Tag Archives: NNRTI

Does The Taxpayer Get Rewarded For Funding Such Studies?

Posted on by — No Comments ↓

Cabotegravir (S-1265744) is an integrase inhibitor similar to dolutegravir.  When formulated as a long-acting drug using crystalline nanoparticle technology it is called GSK’744 LAP.  When injected intramuscularly, ‘744 LAP it has a half-life of >1 month which makes it ideally Continue reading Does The Taxpayer Get Rewarded For Funding Such Studies?→

Should Efavirenz Remain a Tier 1 ART Drug?

Posted on by — No Comments ↓

In a recent publication Raffi et al. suggest that it may be time to drop efavirenz (Sustiva®) from 1st line HIV treatment recommendations [1].  The authors make the claim that efavirenz was inferior to rilpivirin (Edurant®) and dolutegravir (Tivicay®) in a total of Continue reading Should Efavirenz Remain a Tier 1 ART Drug?→